by David Kent | Aug 2, 2016
Last week, a good friend of mine forwarded me a correspondence from the New England Journal of Medicine (NEJM). I was expecting to read about a new drug being tested in clinical trials or maybe a neat scientific perspective on leukemia biology, but what I got instead...
by David Kent | Jul 18, 2016
During the morning plenary session on the final day of ISSCR, we were treated to a delightful mix of basic and translational science as well as a riveting public policy lecture from Alta Charo. The session was all about disease modeling and stem cells and the...
by David Kent | May 31, 2016
Throughout the last decade, I have undertaken research in the stem cell field in two countries (Canada and the United Kingdom) and while my work has never involved the ethically contentious human embryonic stem (ES) cell lines, I have interacted with dozens of...
by Nicole Kuchinsky | Mar 31, 2016
Stem cell technology and reproductive medicine have always been tightly linked. After all, the early embryo is essentially a ball of stem cells. For this post, I will delve into a hot topic in reproductive medicine—three-person embryos. Similar to what we have seen...
by James Smith | Mar 7, 2016
Post by James Smith and Mackenna Roberts. Ms. Roberts is an English-qualified lawyer, trained bioethicist and strategic adviser for the commercialization of emerging biomedical technologies and is widely published on how the law should govern cutting-edge medical...
Comments